What disease does Axitinib treat?

Axitinib (Axitinib) is a targeted therapy drug mainly used to treat advanced renal cell carcinoma (renal cell carcinoma, RCC), which is a malignant tumor that occurs in the kidneys. Renal cell carcinoma accounts for the majority of all kidney cancers, and advanced renal cell carcinoma usually manifests as tumor spread to surrounding tissues or distant organs, making traditional treatments such as surgery difficult to implement.

Axitinib is a targeted drug that mainly exerts its therapeutic effect by inhibiting vascular endothelial growth factor receptor (VEGFR). VEGFRPlays a key role in tumor growth by promoting the formation of new blood vessels and providing more nutrients and oxygen to tumors, thereby promoting tumor growth and spread. The mechanism of action of axitinib mainly focuses on inhibiting this biological process and slowing down the growth rate of tumor cells.

Clinical trials and studies have proven that axitinib has significant efficacy in the treatment of renal cell carcinoma. It is widely used in patients with advanced renal cell carcinoma, especially those who cannot be removed by surgery or who do not respond well to other treatment modalities. The drug is included in multiple international clinical treatment guidelines and is considered one of the effective options for first-line treatment.

However, axitinib is not suitable for all patients with renal cell carcinoma, and its use should be based on the patient's specific situation and physician's recommendations. Patients should discuss the potential benefits and risks in detail with their doctor before receiving treatment and closely monitor the patient's condition and drug side effects during treatment. Through personalized treatment options, axitinib provides a more precise and effective treatment option for patients with advanced renal cell carcinoma.

Axitinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price of 5mg*28 tablets is about 5,000 to 6,000 yuan. For specific prices, please consult the local hospital pharmacy. There are original and generic axitinib drugs abroad. The original drug is Pfizer's original drug, and the price is about 6,000 yuan; the generic drugs are mainly Bangladeshi generics and Indian generics. The price of Bangladeshi generics in 5mg*60 tablets is more than 1,000 yuan, and the price of Indian generics is around a few hundred yuan. The ingredients of original drugs and generic drugs are basically the same.